Physician profile
Ryan Kaple
NPI 1154580694
$178,045.39
in general payments reported to CMS, 2019-2025
27 companies · $53K in 2025
The $53K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,579 · 2020: $4,456 · 2021: $16K · 2022: $36K · 2023: $20K · 2024: $39K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Travel and Lodging: $20K · Food and Beverage: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,750 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $59,765.00 |
| Travel and Lodging | $20,022.75 |
| Food and Beverage | $17,387.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,750.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $134,123.42 | 2019-2025 | Mitraclip, Triclip, Cardiomems |
| Medtronic, INC. | $17,746.47 | 2021-2025 | Corevalve Evolut R, Micra |
| Edwards Lifesciences Corporation | $16,125.05 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque, Pascal |
| Medtronic Vascular, INC. | $5,275.62 | 2019-2020 | |
| Boston Scientific Corporation | $1,366.28 | 2019-2025 | Accolade Sr, Watchman Flx, Bodyguardian |
| Ancora Heart, INC. | $1,140.15 | 2021-2024 | Accucinch |
| Abiomed | $548.34 | 2022-2025 | Impella |
| Siemens Medical Solutions USA, INC. | $241.28 | 2022-2024 | Naeotom Alpha |
| W. L. Gore & Associates, INC. | $217.48 | 2023-2025 | Gore Cardioform Septal Occluder, Gore Septal Occluder |
| Cardiva Medical, INC. | $192.53 | 2022-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Endologix LLC | $150.00 | 2025 | Endocross Device, Torus Stent Graft System |
| Almirall LLC | $149.51 | 2019 | |
| Ambu INC. | $117.88 | 2023 | |
| Cardinal Health 200 LLC | $117.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $84.52 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiac Dimensions, INC. | $67.99 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $62.52 | 2024 | Optimizer |
| Acist Medical Systems, INC. | $55.92 | 2024-2025 | |
| Getinge USA Sales, LLC | $43.56 | 2022 | |
| Heartflow, INC. | $43.52 | 2025 | |
| Ethicon US, LLC | $35.47 | 2025 | Vistaseal, Dermabond Prineo, Evarrest |
| Haemonetics Corporation | $29.22 | 2024 | Teg6s Hemostasis System |
| Atricure, INC. | $25.64 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Amgen INC. | $23.77 | 2021 | |
| Inari Medical, INC. | $22.92 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Irhythm Technologies, INC. | $19.71 | 2023 | Zio Monitor, Zio Xt Patch |
| Pfizer INC. | $19.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kaple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.